Hitendra Shaligram Mahajan
Research Subjects
Research Interests
Hitendra Shaligram Mahajan has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Surendra G. Gattani
3 shared publications- Pankaj Nerkar
R C Patel Institute of Pharmaceutical Education and Research, Shirpur, 425405, (MS), India
2 shared publications Sanjay J. Surana
Department of Pharmaceutics R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur Dist, Dhule, India
2 shared publications- Subhash Deshmane
RSCP: Rajarshi Shahu College of Pharmacy
2 shared publications - Surendra Gattani
School of Pharmacy, Swami Ramanand Teerth Marathwada University, Vishnupuri, Nanded, 431606, Maharashtra, India
2 shared publications Yogesh A. Sonar
2 shared publications
Latest Publications
- 23 October 2026
- Published by Manuscript Technomedia LLP in Indian Journal of Pharmaceutical Education and Research
- Vol. 61 (1) , 15-23
Microneedles as Novel Drug Delivery Platforms: Fabrication Techniques, Evaluation Methods, and Clinical Potential
Microneedle-based drug delivery has received considerable attention and is rapidly approaching commercialisation owing to the availability of different scalable techniques to yield various microneedles. Numerous materials such as metals, silicones, polymers, and carbohydrates have been employed to fabricate microneedles. Microneedles offer a range of benefits to patients, not only because of their minimally invasive and comfortable nature, but also because of their availability in various geometries. Microneedles are useful for various applications, such as topical, ocular, and nail delivery of small drug molecules, proteins, peptides, and nucleotides. Various fabrication methods for microneedles have been tested for various compounds. Different evaluation tests have been conducted to demonstrate the applicability of microneedles for the delivery of a variety of materials in a desired manner. Microneedles are used in vaccine administration, drug delivery, and cosmetic applications. However, certain issues such as the selection of suitable substances and fabrication techniques that meet the requirements of drug delivery need to be investigated.
- 23 October 2026
- Published by Manuscript Technomedia LLP in Indian Journal of Pharmaceutical Education and Research
- Vol. 61 (1) , 15-23
Microneedles as Novel Drug Delivery Platforms: Fabrication Techniques, Evaluation Methods, and Clinical Potential
Microneedle-based drug delivery has received considerable attention and is rapidly approaching commercialisation owing to the availability of different scalable techniques to yield various microneedles. Numerous materials such as metals, silicones, polymers, and carbohydrates have been employed to fabricate microneedles. Microneedles offer a range of benefits to patients, not only because of their minimally invasive and comfortable nature, but also because of their availability in various geometries. Microneedles are useful for various applications, such as topical, ocular, and nail delivery of small drug molecules, proteins, peptides, and nucleotides. Various fabrication methods for microneedles have been tested for various compounds. Different evaluation tests have been conducted to demonstrate the applicability of microneedles for the delivery of a variety of materials in a desired manner. Microneedles are used in vaccine administration, drug delivery, and cosmetic applications. However, certain issues such as the selection of suitable substances and fabrication techniques that meet the requirements of drug delivery need to be investigated.
- 18 August 2026
- Published by Taylor & Francis in Drying Technology
- p. 1-18
Development and characterization of Trojan microspheres based dry powder inhalers for delivery of antitubercular agent
1. Tuberculosis (TB) is still a leading worldwide health isssue, caused by the bacterium Mycobacterium tuberculosis (MTb). Despite being a preventable and curable disease, as per recent WHO reports...
- 18 August 2026
- Published by Taylor & Francis in Drying Technology
- p. 1-18
Development and characterization of Trojan microspheres based dry powder inhalers for delivery of antitubercular agent
1. Tuberculosis (TB) is still a leading worldwide health isssue, caused by the bacterium Mycobacterium tuberculosis (MTb). Despite being a preventable and curable disease, as per recent WHO reports...
- 10 March 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (3) , 274
Mesoporous Silica Nanoparticles for Improved Solubility and Bioavailability of Pazopanib in the Treatment of Renal Cell Carcinoma
- 10 March 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (3) , 274
Mesoporous Silica Nanoparticles for Improved Solubility and Bioavailability of Pazopanib in the Treatment of Renal Cell Carcinoma
- Top Cited Papers
- 11 December 2025
- Published by Elsevier in Ageing Research Reviews
- Vol. 114, 102990
Unveiling Alzheimer’s disease (1901–2025): Historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies
- 11 December 2025
- Published by Elsevier in Ageing Research Reviews
- Vol. 114, 102990
Top Cited PapersUnveiling Alzheimer’s disease (1901–2025): Historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies
- Open Access
- 2 December 2025
- Published by International Association of Physical Chemists (IAPC) in ADMET and DMPK
- Vol. 14, 2967
Intranasal carvacrol nanoemulsion: Stroke imaging and neuroprotective study
Background and purpose: Cerebral ischemia causes neuronal damage due to restricted blood flow and presents significant challenges for brain-targeted drug delivery because of the blood-brain barrier. The purpose of this study is to formulate and evaluate an intranasal oil-in-water nanoemulsion of carvacrol, a neuroprotective agent, for direct nose-to-brain delivery in treating cerebral ischemia. Experimental approach: Nanoemulsions were developed using high-pressure homogenization and optimized by adjusting surfactant mixture ratios and homogenization cycles. Characterization included droplet size (<200 nm), polydispersity index, zeta potential, drug content, transmission electron microscopy (TEM), and drug release profiles. Intranasal suitability was assessed through in vitro, ex vivo and in vivo studies, including pharmacokinetics, single photon emission computed tomography (SPECT) imaging, and evaluation in a middle cerebral artery occlusion rat model. Key results: The optimized nanoemulsion showed sustained release, enhanced nasal permeation, and significantly improved brain bioavailability (Cmax = 67.79 ng mL-1 intranasal vs. 49.71 ng mL-1 intravenous). Lower systemic exposure and high targeting indices (DTE: 1317 %; DTP: 92.40 %) confirmed efficient brain delivery. SPECT imaging validated localized uptake, and the ischemia model demonstrated strong neuroprotective efficacy. Conclusion: Intranasal carvacrol-loaded nanoemulsion is a promising non-invasive strategy for cerebral ischemia treatment, enabling effective brain targeting and significant therapeutic benefit.
- 2 December 2025
- Published by International Association of Physical Chemists (IAPC) in ADMET and DMPK
- Vol. 14, 2967
Open AccessIntranasal carvacrol nanoemulsion: Stroke imaging and neuroprotective study
Background and purpose: Cerebral ischemia causes neuronal damage due to restricted blood flow and presents significant challenges for brain-targeted drug delivery because of the blood-brain barrier. The purpose of this study is to formulate and evaluate an intranasal oil-in-water nanoemulsion of carvacrol, a neuroprotective agent, for direct nose-to-brain delivery in treating cerebral ischemia. Experimental approach: Nanoemulsions were developed using high-pressure homogenization and optimized by adjusting surfactant mixture ratios and homogenization cycles. Characterization included droplet size (<200 nm), polydispersity index, zeta potential, drug content, transmission electron microscopy (TEM), and drug release profiles. Intranasal suitability was assessed through in vitro, ex vivo and in vivo studies, including pharmacokinetics, single photon emission computed tomography (SPECT) imaging, and evaluation in a middle cerebral artery occlusion rat model. Key results: The optimized nanoemulsion showed sustained release, enhanced nasal permeation, and significantly improved brain bioavailability (Cmax = 67.79 ng mL-1 intranasal vs. 49.71 ng mL-1 intravenous). Lower systemic exposure and high targeting indices (DTE: 1317 %; DTP: 92.40 %) confirmed efficient brain delivery. SPECT imaging validated localized uptake, and the ischemia model demonstrated strong neuroprotective efficacy. Conclusion: Intranasal carvacrol-loaded nanoemulsion is a promising non-invasive strategy for cerebral ischemia treatment, enabling effective brain targeting and significant therapeutic benefit.
- 21 October 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (6) , 1-19
A Comprehensive Review of Nanoemulsion Via the Nose To the Brain in the Management of Parkinson’s Disease
- 21 October 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20 (6) , 1-19
A Comprehensive Review of Nanoemulsion Via the Nose To the Brain in the Management of Parkinson’s Disease
- 10 October 2025
- Published by Institutul de Chimie Macromoleculara Petru Poni in Cellulose Chemistry and Technology
- Vol. 59 (7-8) , 803-815
THERMORESPONSIVE IN-SITU GELLING OPHTHALMIC DRUG DELIVERY SYSTEM BASED ON XYLOGLUCAN CONTAINING TRIAMCINOLONE ACETONIDE NANOPARTICLES
This investigation explores the feasibility of using a gel formulation composed of xyloglucan for the administration of triamcinolone acetonide (TA) nanoparticles in ophthalmic drug delivery systems. The solvent evaporation method with lyophilization was employed to develop TA-loaded β-cyclodextrin (βCD)-Soluplus (Solu) nanoparticles (NPs), which were subsequently optimized using the response surface methodology (central composite design, CCD), indicating that the independent variables had a significant impact on particle size and percentage encapsulation. In addition to solid-state assessment using FTIR, XRD, DSC, and surface properties using scanning and transmission electron microscopy (SEM and TEM), the developed nanoparticles were confirmed to have a nanospherical structure and a stable formulation. The release profile and in vitro and ex vivo assessments were utilized to evaluate the drug discharge mechanisms of the developed formulation, which showed prolonged release for 8 h. The optimized formulation exhibited improved corneal permeation compared to the pure drug and showed no irritancy, as evidenced by the HET-CAM test.
- 10 October 2025
- Published by Institutul de Chimie Macromoleculara Petru Poni in Cellulose Chemistry and Technology
- Vol. 59 (7-8) , 803-815
THERMORESPONSIVE IN-SITU GELLING OPHTHALMIC DRUG DELIVERY SYSTEM BASED ON XYLOGLUCAN CONTAINING TRIAMCINOLONE ACETONIDE NANOPARTICLES
This investigation explores the feasibility of using a gel formulation composed of xyloglucan for the administration of triamcinolone acetonide (TA) nanoparticles in ophthalmic drug delivery systems. The solvent evaporation method with lyophilization was employed to develop TA-loaded β-cyclodextrin (βCD)-Soluplus (Solu) nanoparticles (NPs), which were subsequently optimized using the response surface methodology (central composite design, CCD), indicating that the independent variables had a significant impact on particle size and percentage encapsulation. In addition to solid-state assessment using FTIR, XRD, DSC, and surface properties using scanning and transmission electron microscopy (SEM and TEM), the developed nanoparticles were confirmed to have a nanospherical structure and a stable formulation. The release profile and in vitro and ex vivo assessments were utilized to evaluate the drug discharge mechanisms of the developed formulation, which showed prolonged release for 8 h. The optimized formulation exhibited improved corneal permeation compared to the pure drug and showed no irritancy, as evidenced by the HET-CAM test.
- 17 March 2025
- Published by Bentham Science Publishers Ltd. in Current Applied Polymer Science
- Vol. 08, 1-24
Polysaccharides from Nature to Technology: Grafting Techniques and their Applications
Polysaccharides, naturally occurring and renewable biopolymers, have garnered significant attention due to their structural versatility and wide-ranging applications across the biomedical, pharmaceutical, and industrial sectors. This review explores the role of polysaccharides as excipients and their emerging importance in drug delivery systems, gene therapy, tissue engineering, medical implants, and biosensing. With detailed insights into their antioxidant, antiinflammatory, and anticancer properties, the review highlights the significance of polysaccharides, such as chitosan, alginates, cellulose, hyaluronic acid, pullulans, and xanthan gum, in developing advanced biomaterials. Various grafting techniques, including chemical and physical methods, are examined for their potential to modify surface properties and enhance biocompatibility, targeting ability, and mechanical strength. Despite the promising biomedical applications, challenges persist in optimizing grafting techniques, ensuring biocompatibility, and overcoming regulatory hurdles. This review also enlightens the current market potential of polysaccharides, emphasizing the growing demand for natural and plant-based materials. Future directions should focus on enhancing the scalability of production, improving chemical modification processes, and addressing technical limitations in tissue engineering applications.
- 17 March 2025
- Published by Bentham Science Publishers Ltd. in Current Applied Polymer Science
- Vol. 08, 1-24
Polysaccharides from Nature to Technology: Grafting Techniques and their Applications
Polysaccharides, naturally occurring and renewable biopolymers, have garnered significant attention due to their structural versatility and wide-ranging applications across the biomedical, pharmaceutical, and industrial sectors. This review explores the role of polysaccharides as excipients and their emerging importance in drug delivery systems, gene therapy, tissue engineering, medical implants, and biosensing. With detailed insights into their antioxidant, antiinflammatory, and anticancer properties, the review highlights the significance of polysaccharides, such as chitosan, alginates, cellulose, hyaluronic acid, pullulans, and xanthan gum, in developing advanced biomaterials. Various grafting techniques, including chemical and physical methods, are examined for their potential to modify surface properties and enhance biocompatibility, targeting ability, and mechanical strength. Despite the promising biomedical applications, challenges persist in optimizing grafting techniques, ensuring biocompatibility, and overcoming regulatory hurdles. This review also enlightens the current market potential of polysaccharides, emphasizing the growing demand for natural and plant-based materials. Future directions should focus on enhancing the scalability of production, improving chemical modification processes, and addressing technical limitations in tissue engineering applications.
- Open Access
- 18 November 2024
- Published by Manuscript Technomedia LLP in Indian Journal of Pharmaceutical Education and Research
- Vol. 58 (4s) , s1156-s1168
Spray Dried Nanoparticle for Pulmonary Delivery: Current Developments and Future Perspectives
Aim: The study aims to comprehensively review advancements in spray-dried nanoparticles for pulmonary drug delivery. It focuses on understanding current techniques, nanoparticle types and applications. Additionally, it aims to identify challenges, assess developments critically and propose future perspectives. The research explores strategies to enhance nanoparticle efficiency, safety and targeted lung delivery. The ultimate goal is to provide valuable insights guiding researchers, pharmaceutical scientists and healthcare professionals in optimizing the design for improved therapeutic strategies in respiratory diseases, leading to better patient outcomes. Background: Dry Powder Inhalers (DPIs) have emerged as a popular method for delivering therapeutic aerosols to the lungs, targeting respiratory conditions including lung cancer, asthma, COPD, cystic fibrosis and pulmonary arterial hypertension. With their huge surface area for absorption, lower metabolic activity than other organs, many capillaries and thin air-blood barrier, the lungs will be significant advantages for systemic medication administration. The particle size shall play a significant role in their deposition in the respiratory tract. Conclusion: A promising formulation technique that combines the advantages of nanotherapeutics and the aerodynamics necessary for effective pulmonary medication administration is combined by controlled agglomeration of Nanoparticles (NPs) into micron-sized clusters. For the creation of microparticles from colloidal solutions containing NPs, spray drying is a flexible approach that is frequently used. The formulation and process characteristics of NP-based drug delivery systems, as well as improvements in spray drying technology. To promote their commercialization, future research should concentrate on scaling up the manufacturing of NP agglomerates and establishing downstream processing strategies.
- 18 November 2024
- Published by Manuscript Technomedia LLP in Indian Journal of Pharmaceutical Education and Research
- Vol. 58 (4s) , s1156-s1168
Open AccessSpray Dried Nanoparticle for Pulmonary Delivery: Current Developments and Future Perspectives
Aim: The study aims to comprehensively review advancements in spray-dried nanoparticles for pulmonary drug delivery. It focuses on understanding current techniques, nanoparticle types and applications. Additionally, it aims to identify challenges, assess developments critically and propose future perspectives. The research explores strategies to enhance nanoparticle efficiency, safety and targeted lung delivery. The ultimate goal is to provide valuable insights guiding researchers, pharmaceutical scientists and healthcare professionals in optimizing the design for improved therapeutic strategies in respiratory diseases, leading to better patient outcomes. Background: Dry Powder Inhalers (DPIs) have emerged as a popular method for delivering therapeutic aerosols to the lungs, targeting respiratory conditions including lung cancer, asthma, COPD, cystic fibrosis and pulmonary arterial hypertension. With their huge surface area for absorption, lower metabolic activity than other organs, many capillaries and thin air-blood barrier, the lungs will be significant advantages for systemic medication administration. The particle size shall play a significant role in their deposition in the respiratory tract. Conclusion: A promising formulation technique that combines the advantages of nanotherapeutics and the aerodynamics necessary for effective pulmonary medication administration is combined by controlled agglomeration of Nanoparticles (NPs) into micron-sized clusters. For the creation of microparticles from colloidal solutions containing NPs, spray drying is a flexible approach that is frequently used. The formulation and process characteristics of NP-based drug delivery systems, as well as improvements in spray drying technology. To promote their commercialization, future research should concentrate on scaling up the manufacturing of NP agglomerates and establishing downstream processing strategies.
- 15 June 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 98
Dendrimers for drug delivery: An overview of its classes, synthesis, and applications
- 15 June 2024
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 98
Dendrimers for drug delivery: An overview of its classes, synthesis, and applications